
Metcamp 47.5mg Tablet XL
Marketer
Lakarez Pharmaceuticals Private Limited
Salt Composition
Metoprolol Succinate (47.5mg)
Overview Metcamp 47.5mg Tablet XL
CardioBeta XL 47.5mg tablets are beta-blockers used to manage hypertension, angina pectoris, and cardiac arrhythmias. This medication also helps prevent migraine recurrence, myocardial infarction, and cerebrovascular accidents. CardioBeta XL 47.5mg may be prescribed individually or in conjunction with other therapies. Dosage and frequency are condition- and severity-dependent. Administer consistently at the same time daily, with or without food, for optimal efficacy. Full therapeutic benefit may take weeks to manifest, and long-term use is often necessary. Discontinuation may exacerbate underlying conditions. Common, usually transient, side effects include fatigue, cephalgia, depressive symptoms, diarrhea, dermatological reactions, bradycardia, dizziness, and nausea. Less frequent adverse events include dyspnea and hypotension. Gradual dose escalation minimizes adverse effects. Report persistent or bothersome side effects to your physician. Prior to commencing treatment, inform your doctor of any hepatic impairment. CardioBeta XL 47.5mg is contraindicated in patients with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating individuals should seek medical counsel. Individual suitability should be confirmed through consultation. Regular blood pressure monitoring is crucial to assess treatment effectiveness. Alcohol consumption should be limited due to potential exacerbation of side effects.
Primary Ingredients of Metcamp 47.5mg Tablet XL
No text was provided to rewrite.
Uses of Metcamp 47.5mg Tablet XL
Managing angina pectoris (chest pain due to heart ischemia)|Correcting cardiac arrhythmias|Reducing the risk of myocardial infarction|Controlling hypertension (elevated blood pressure)|Preventing migraine headaches
Major Benefits of Metcamp 47.5mg Tablet XL:
Follow your doctor's instructions precisely regarding dosage and treatment length for Metcamp 47.5mg Extended-Release Tablets. Ingest the tablet whole; do not chew, crush, or divide it. These tablets can be taken with or without food, but consistent timing is recommended. High-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and meat, should be avoided when taking Metcamp 47.5mg Extended-Release Tablets.
Common Side effects of Metcamp 47.5mg Tablet XL:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metcamp 47.5mg Tablet XL:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the 47.5mg extended-release Metcamp tablet whole; do not crush, chew, or break it. This medication can be taken with or without food, but consistent timing is recommended. Minimize consumption of high-fat foods like olive oil, nuts (including Brazil nuts), dark chocolate, butter, and meat while taking Metcamp 47.5mg Tablet XL.
How Metcamp 47.5mg Tablet XL works:
Extended-release Metcamp 47.5mg tablets are a cardioselective beta-adrenergic blocker. They reduce heart rate and improve the heart's pumping efficiency, thus enhancing circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metcamp 47.5mg Tablet XL with alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metcamp 47.5mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metcamp 47.5mg tablets are likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Metcamp 47.5mg tablets can reduce alertness, impair vision, and induce drowsiness or dizziness. Driving is inadvisable if such effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Metcamp 47.5mg tablets are considered safe for use in individuals with renal impairment. No alteration of the Metcamp 47.5mg extended-release tablet dosage is necessary.
LiverCAUTION
Extended-release Metcamp 47.5mg tablets require careful administration in individuals with hepatic impairment. Dosage modification of Metcamp 47.5mg extended-release tablets might be necessary. Physician consultation is advised.
What if you forget to take Metcamp 47.5mg Tablet XL :
Should you forget a Metcamp 47.5mg Tablet XL dose, administer it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metcamp 47.5mg Tablet XL
| Label | Value |
|---|---|
| Chemical Category | Alcohols and Phenols |
| Developing Habits | No. |
| Type of Therapy | Heart |
